BIMI International Medical Inc. (BIMI)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 3.11 Million USD | -62.13% |
| 2021 | 8.23 Million USD | 68.14% |
| 2020 | 4.89 Million USD | 6796.77% |
| 2019 | 71.02 Thousand USD | -98.78% |
| 2018 | 5.79 Million USD | -16.46% |
| 2017 | 6.94 Million USD | 23.16% |
| 2016 | 5.63 Million USD | -26.07% |
| 2015 | 7.62 Million USD | -11.83% |
| 2014 | 8.64 Million USD | 17.66% |
| 2013 | 7.34 Million USD | 10.22% |
| 2012 | 6.66 Million USD | -10.78% |
| 2011 | 7.47 Million USD | 254.6% |
| 2010 | 2.1 Million USD | 900.79% |
| 2009 | 210.58 Thousand USD | 109.35% |
| 2008 | -2.25 Million USD | -0.53% |
| 2007 | -2.24 Million USD | -181.19% |
| 2006 | -796.94 Thousand USD | -300.2% |
| 2005 | 398.07 Thousand USD | 29.42% |
| 2004 | 307.57 Thousand USD | 194.67% |
| 2003 | 104.38 Thousand USD | -29.73% |
| 2002 | 148.53 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | 3.47 Million USD | 39.25% |
| 2023 Q1 | 3.44 Million USD | 10.6% |
| 2023 Q2 | 2.49 Million USD | -27.63% |
| 2022 Q3 | 11.56 Million USD | 39.04% |
| 2022 Q2 | 8.32 Million USD | -28.79% |
| 2022 FY | 3.11 Million USD | -62.13% |
| 2022 Q4 | 3.11 Million USD | -73.04% |
| 2022 Q1 | 11.68 Million USD | 41.89% |
| 2021 Q3 | 11.18 Million USD | -5.51% |
| 2021 FY | 8.23 Million USD | 68.14% |
| 2021 Q1 | 6.33 Million USD | 29.27% |
| 2021 Q2 | 11.83 Million USD | 86.92% |
| 2021 Q4 | 8.23 Million USD | -26.35% |
| 2020 Q3 | -6.77 Million USD | -236.28% |
| 2020 Q4 | 4.89 Million USD | 172.25% |
| 2020 Q2 | 4.97 Million USD | 233.06% |
| 2020 Q1 | 1.49 Million USD | 2002.84% |
| 2020 FY | 4.89 Million USD | 6796.77% |
| 2019 Q1 | 5.63 Million USD | -2.77% |
| 2019 FY | 71.02 Thousand USD | -98.78% |
| 2019 Q4 | 71.02 Thousand USD | -98.73% |
| 2019 Q3 | 5.59 Million USD | -2.28% |
| 2019 Q2 | 5.72 Million USD | 1.46% |
| 2018 Q1 | 6.12 Million USD | -11.82% |
| 2018 Q2 | 6.57 Million USD | 7.44% |
| 2018 FY | 5.79 Million USD | -16.46% |
| 2018 Q3 | 5.62 Million USD | -14.49% |
| 2018 Q4 | 5.79 Million USD | 3.12% |
| 2017 Q2 | 5.88 Million USD | 1.74% |
| 2017 Q1 | 5.78 Million USD | 2.66% |
| 2017 Q3 | 5.99 Million USD | 1.77% |
| 2017 Q4 | 6.94 Million USD | 15.88% |
| 2017 FY | 6.94 Million USD | 23.16% |
| 2016 Q1 | 5.83 Million USD | -23.5% |
| 2016 FY | 5.63 Million USD | -26.07% |
| 2016 Q2 | 5.86 Million USD | 0.57% |
| 2016 Q3 | 5.77 Million USD | -1.5% |
| 2016 Q4 | 5.63 Million USD | -2.43% |
| 2015 Q4 | 7.62 Million USD | 23.99% |
| 2015 Q3 | 6.14 Million USD | -25.67% |
| 2015 FY | 7.62 Million USD | -11.83% |
| 2015 Q2 | 8.27 Million USD | 6.22% |
| 2015 Q1 | 7.78 Million USD | -9.94% |
| 2014 Q2 | 7.23 Million USD | -7.54% |
| 2014 Q4 | 8.64 Million USD | 4.66% |
| 2014 Q1 | 7.82 Million USD | 6.46% |
| 2014 FY | 8.64 Million USD | 17.66% |
| 2014 Q3 | 8.26 Million USD | 14.22% |
| 2013 Q2 | 8.9 Million USD | 29.58% |
| 2013 Q3 | 8.02 Million USD | -9.9% |
| 2013 Q4 | 7.34 Million USD | -8.4% |
| 2013 FY | 7.34 Million USD | 10.22% |
| 2013 Q1 | 6.87 Million USD | 3.06% |
| 2012 Q1 | 6.28 Million USD | -15.96% |
| 2012 Q3 | 8.68 Million USD | 23.63% |
| 2012 Q2 | 7.02 Million USD | 11.87% |
| 2012 FY | 6.66 Million USD | -10.78% |
| 2012 Q4 | 6.66 Million USD | -23.24% |
| 2011 Q3 | 5.54 Million USD | 3.57% |
| 2011 FY | 7.47 Million USD | 254.6% |
| 2011 Q4 | 7.47 Million USD | 34.83% |
| 2011 Q2 | 5.35 Million USD | 90.45% |
| 2011 Q1 | 2.81 Million USD | 33.34% |
| 2010 Q3 | 676.2 Thousand USD | -44.2% |
| 2010 Q1 | 368.31 Thousand USD | 74.9% |
| 2010 Q4 | 2.1 Million USD | 211.67% |
| 2010 FY | 2.1 Million USD | 900.79% |
| 2010 Q2 | 1.21 Million USD | 229.03% |
| 2009 FY | 210.58 Thousand USD | 109.35% |
| 2009 Q2 | -802.67 Thousand USD | 44.31% |
| 2009 Q3 | 790.41 Thousand USD | 198.47% |
| 2009 Q1 | -1.44 Million USD | 36.02% |
| 2009 Q4 | 210.58 Thousand USD | -73.36% |
| 2008 Q2 | -4.76 Million USD | -20.41% |
| 2008 Q4 | -2.25 Million USD | 22.44% |
| 2008 FY | -2.25 Million USD | -0.53% |
| 2008 Q3 | -2.9 Million USD | 38.99% |
| 2008 Q1 | -3.95 Million USD | -76.46% |
| 2007 Q1 | -36 Thousand USD | 95.48% |
| 2007 Q4 | -2.24 Million USD | -244.86% |
| 2007 Q3 | -649.8 Thousand USD | 66.51% |
| 2007 FY | -2.24 Million USD | -181.19% |
| 2007 Q2 | -1.94 Million USD | -5288.71% |
| 2006 Q1 | 3401.00 USD | -99.15% |
| 2006 Q2 | 30.56 Thousand USD | 798.77% |
| 2006 Q4 | -796.94 Thousand USD | -85317.36% |
| 2006 Q3 | -933.00 USD | -103.05% |
| 2006 FY | -796.94 Thousand USD | -300.2% |
| 2005 Q1 | 360.88 Thousand USD | 17.33% |
| 2005 Q4 | 398.07 Thousand USD | 1.78% |
| 2005 Q2 | 367.38 Thousand USD | 1.8% |
| 2005 Q3 | 391.12 Thousand USD | 6.46% |
| 2005 FY | 398.07 Thousand USD | 29.42% |
| 2004 Q3 | 276.67 Thousand USD | 68.26% |
| 2004 FY | 307.57 Thousand USD | 194.67% |
| 2004 Q2 | 164.43 Thousand USD | 2.73% |
| 2004 Q4 | 307.57 Thousand USD | 11.17% |
| 2004 Q1 | 160.06 Thousand USD | 53.35% |
| 2003 FY | 104.38 Thousand USD | -29.73% |
| 2003 Q3 | 6828.00 USD | 439.87% |
| 2003 Q4 | 104.38 Thousand USD | 1428.71% |
| 2003 Q2 | -2009.00 USD | 49.48% |
| 2003 Q1 | -3977.00 USD | -102.68% |
| 2002 FY | 148.53 Thousand USD | 0.0% |
| 2002 Q4 | 148.53 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -655.73 Thousand USD | 575.608% |
| China Jo-Jo Drugstores, Inc. | 10.34 Million USD | 69.855% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 116.41 Million USD | 97.321% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 109.08 Million USD | 97.141% |
| Leafly Holdings, Inc. | 13.79 Million USD | 77.388% |
| Leafly Holdings, Inc. | 13.79 Million USD | 77.388% |
| LifeMD, Inc. | -14.21 Million USD | 121.941% |
| LifeMD, Inc. | -14.21 Million USD | 121.941% |
| TRxADE HEALTH, Inc. | 6.95 Million USD | 55.139% |
| PetMed Express, Inc. | -53.84 Million USD | 105.792% |
| Walgreens Boots Alliance, Inc. | 8.23 Billion USD | 99.962% |